Investing in tomorrow's healthcare

Successful Investments

BeamLine Diagnostics is developing a biopsy triaging system that can identify healthy and benign tissue specimens with high accuracy within seconds.
HQ: Didcot
CEO: Liberty Foreman
Website: beamlinediagnostics.com
Clustermarket gives scientists the opportunity to access latest technology in an easy and affordable way by providing an online sharing platform.
HQ: London
CEO: Johannes Solzbach
Website: clustermarket.com
LiveSmart is developing a digital health improvement platform that is effective at driving behaviour change.
HQ: London
CEO: Alex Heaton
Website: getlivesmart.com
The Electrospinning Company designs, develops and manufactures biomaterials for use in regenerative medical devices.
HQ: Oxfordshire
CEO: Ann Kramer
Website: electrospinning.co.uk
Eagle Genomics develops software solutions for pharmaceutical, biotech and personal care product companies to bring new candidate medicines, therapies and products to patients and customers more quickly.
HQ: Cambridge
CEO: Abel Ureta-Vidal
Website: eaglegenomics.com
Oppilotech develops novel antibacterial compounds against drug resistant organisms.
HQ: London
CEO: Ajay Mistry
Website: oppilotech.com
mOm Incubators has developed an inexpensive, electronically controlled, inflatable infant incubator designed and built to decrease the number of infant deaths.
HQ: London
CEO: James Roberts
Website: momincubators.com
Jupiter Diagnostics has developed a point-of-care diagnostic reader, allowing anyone to perform quick, affordable blood tests.
HQ: London
CEO: Chris Ball
Website: jupiterdiagnostics.com
OxTex is pioneering novel tissue expander solutions for the primary use in reconstructive and dental surgery
HQ: Oxford
CEO: David Jackson
Website: oxtex.com
Camstent has invented a catheter coating to prevent infection and reduce associated costs.
HQ: Cambridge
CEO: Paul Harper
Website: camstent.com
Sense is developing user-centred, handheld diagnostic test devices in the fields of infection and oncology.
HQ: Oxford
CEO: Harry Lamble
Website: sense-bio.com
Jellagen produces research grade functional non-mammalian collagen products sourced from jellyfish.
HQ: Cardiff
CEO: Andrew Mearns Spragg
Website: jellagen.co.uk
Nalia Systems  is a developer of customisable immunodiagnostic systems that accelerate biomedical research and drug discovery and development, producing simple, accurate and cost-effective biomarker panels that enable patient stratification and rapid go/no-go decision making.
HQ: London
CEO: Nigel Davis
Website: naliasystems.com
StepJockey is a digital health company that creates healthy, active spaces with their unique smart signs and stair climbing challenges.
HQ: London
CEO: Paul Nuki
Website: stepjockey.com
Desktop Genetics is building a CRISPR AI that enables scientists to modify any cell, in any species by designing and executing personalized CRISPR genome editing, right from their desktop.
HQ: London
CEO: Riley Doyle
Website: deskgen.com

 

Become an Angels in MedCity investor

Become an investor >

 

Become an Angels in MedCity entrepreneur

Entrepreneurs >

 

On Twitter

RT @IanWCampbell: An opportunity for investors to look at life science start-up companies at the @AngelsInMedCity event on 15th Nov. https:…
6 days 15 hours ago
Top tips & pitfalls for entrepreneurs looking for early funding support https://t.co/GX8Y75GKvC
6 days 15 hours ago